Lokavant expands its Global Customer Base and Strengthens Its...
healthcaretechoutlook

Lokavant expands its Global Customer Base and Strengthens Its Leadership Team

Healthcare Tech Outlook | Wednesday, December 29, 2021

Lokavant has formed new cooperation with a renowned global consulting firm to accelerate digital transformation in the life sciences.

Fremont, CA: Lokavant is a clinical intelligence platform that uses data-driven analytics tools to reduce trial execution time, cost, and quality. Lokavant's platform combines and integrates real-time data from multiple trial data sources, and it drives sophisticated analytics provided by its proprietary trial data compendium. The platform's portfolio of tools enables research teams to proactively manage their investigations, uncover insights, and drive efficiency across all scientific and operational use cases.

Lokavant increased its worldwide customer base and new appointments to its leadership team. It has entered into a multi-year business agreement with the CMIC Group, Japan's oldest and biggest contract research firm (CRO). Following a successful initial engagement in which Lokavant structured and harmonized operational data throughout hundreds of historical trials, benchmarked CMIC operating performance, and deployed the real-time risk-based monitoring application, CMIC will leverage Lokavant data harmonization and predictive analytics capabilities across CMIC's ongoing and future trials.

"Like most drug development companies in our region, our data were previously siloed across different teams, source systems, and studies. In just a few weeks, Lokavant was able to connect and harmonize operational data across hundreds of studies and uncover insights about our performance that we had never seen before," said Yoshihito Kondo, Executive Vice President of Clinical Operations at CMIC. "These insights have already helped drive a step-change in performance across our enterprise and enable better time, cost, and quality outcomes for sponsors here in APAC. We are excited to expand our strategic partnership and make Lokavant our clinical trial intelligence solution across all future trials. As the APAC market continues to grow, this partnership will help solidify CMIC's leadership position, driving better, data-driven clinical operations to the region and delivering critical therapies to patients in need."

Lokavant has also forged important new cooperation with Perficient, the world's top digital consultancy with over 6,000 workers. Perficient's current and prospective clients will have a shortened approach to using Lokavant's clinical intelligence platform and next-generation analytical tools.

Weekly Brief